Marsupial cathelicidins: characterization, antimicrobial activity and evolution in this unique mammalian lineage

This study sheds light on the evolutionary history of mammalian cathelicidins and highlights the potential of wildlife for novel bioactive peptide discovery.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-04-04
DOI
https://doi.org/10.3389/fimmu.2025.1524092
Citations
4
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
4.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marsupial cathelicidins: characterization, antimicrobial activity and evolution in this unique mammalian lineage

Katherine Belov, Carolyn J. Hogg, Emma Peel, Adele Gonsalvez
4 citations
Frontiers in Immunology
Antimicrobial Peptides and Activities
4.73
article

Marsupial cathelicidins: characterization, antimicrobial activity and evolution in this unique mammalian lineage

Katherine Belov, Carolyn J. Hogg, Emma Peel, Adele Gonsalvez
article en
4 citations

Abstract

This study sheds light on the evolutionary history of mammalian cathelicidins and highlights the potential of wildlife for novel bioactive peptide discovery.

Frontiers in ImmunologyVol. 16
The University of Sydney (AU), Australian Research Council (AU), ARC Centre of Excellence for Innovations in Peptide and Protein Science (AU)
Princeton University, Australian Wildlife Conservancy, Australian Research Council
Openalex Percentile: Top 5%
Antimicrobial Peptides and Activities
4.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.